While PARP12 has been reported as a tumor suppressor that plays an important role in the suppression of hepatocellular carcinoma metastasis [69], it has also been implicated in coronary heart disease and associated with vitiligo [70,71]. This evidence concerns the gene PARP12 and hepatocellular carcinoma.